IRIS UniCatt

Paris, Ida
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.202
AS - Asia 1.982
EU - Europa 1.254
SA - Sud America 391
AF - Africa 62
Continente sconosciuto - Info sul continente non disponibili 6
OC - Oceania 4
Totale 5.901
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.117
SG - Singapore 898
CN - Cina 355
BR - Brasile 319
VN - Vietnam 295
IT - Italia 262
SE - Svezia 252
DE - Germania 189
FR - Francia 154
IN - India 115
GB - Regno Unito 82
FI - Finlandia 75
HK - Hong Kong 68
IE - Irlanda 66
ID - Indonesia 51
JP - Giappone 38
CA - Canada 37
RU - Federazione Russa 32
MX - Messico 31
AR - Argentina 30
BD - Bangladesh 28
PH - Filippine 22
ZA - Sudafrica 22
PL - Polonia 21
ES - Italia 20
TR - Turchia 19
KR - Corea 18
NL - Olanda 18
AT - Austria 16
BE - Belgio 15
PK - Pakistan 14
UA - Ucraina 14
CI - Costa d'Avorio 13
IQ - Iraq 13
CO - Colombia 11
EC - Ecuador 9
IR - Iran 9
VE - Venezuela 9
MA - Marocco 7
JO - Giordania 6
UZ - Uzbekistan 6
CL - Cile 5
HU - Ungheria 5
KE - Kenya 5
KZ - Kazakistan 5
RO - Romania 5
TN - Tunisia 5
BZ - Belize 4
CR - Costa Rica 4
CZ - Repubblica Ceca 4
EU - Europa 4
JM - Giamaica 4
AU - Australia 3
AZ - Azerbaigian 3
BG - Bulgaria 3
CH - Svizzera 3
EG - Egitto 3
MY - Malesia 3
NP - Nepal 3
PE - Perù 3
SA - Arabia Saudita 3
UY - Uruguay 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AE - Emirati Arabi Uniti 2
AL - Albania 2
CG - Congo 2
ET - Etiopia 2
IL - Israele 2
LT - Lituania 2
MD - Moldavia 2
NO - Norvegia 2
PY - Paraguay 2
RS - Serbia 2
TH - Thailandia 2
AM - Armenia 1
BA - Bosnia-Erzegovina 1
CY - Cipro 1
DZ - Algeria 1
EE - Estonia 1
GD - Grenada 1
HN - Honduras 1
HR - Croazia 1
IM - Isola di Man 1
IS - Islanda 1
KG - Kirghizistan 1
LB - Libano 1
LU - Lussemburgo 1
LV - Lettonia 1
NG - Nigeria 1
NZ - Nuova Zelanda 1
PA - Panama 1
PT - Portogallo 1
SC - Seychelles 1
SV - El Salvador 1
TT - Trinidad e Tobago 1
Totale 5.901
Salva come PNG Salva come JPEG
Città #
Singapore 564
Chandler 278
San Jose 230
Ashburn 217
Ho Chi Minh City 87
New York 82
Council Bluffs 79
Hanoi 74
Beijing 71
Los Angeles 69
Hyderabad 66
Dublin 64
Rome 59
Munich 57
Hong Kong 56
Chicago 55
Lauterbourg 50
Hefei 46
The Dalles 46
Jakarta 41
Milan 41
Frankfurt am Main 38
São Paulo 37
Tokyo 36
Helsinki 35
San Mateo 32
Boston 30
Ann Arbor 29
Wilmington 28
Bremen 26
Princeton 26
Fairfield 24
Turku 23
St Louis 21
Buffalo 20
Haiphong 20
Marseille 19
Paris 19
London 18
Nuremberg 17
Seoul 17
Boardman 16
Jacksonville 16
Santa Clara 16
Orem 15
Salt Lake City 15
Warsaw 15
Brussels 14
Kent 14
Lappeenranta 14
Moscow 14
Nanjing 14
Abidjan 13
Da Nang 13
Rio de Janeiro 12
Seattle 12
Chennai 10
Dallas 10
Izmir 10
Lancaster 10
Montreal 10
North Bergen 10
Phoenix 10
Tampa 10
Brooklyn 9
Cattolica 9
Düsseldorf 9
Houston 9
Johannesburg 9
Vienna 9
Augusta 8
Denver 8
Elk Grove Village 8
Florence 8
Manchester 8
Porto Alegre 8
Stockholm 8
Toronto 8
Mexico City 7
San Francisco 7
Shenzhen 7
Amman 6
Amsterdam 6
Andover 6
Belo Horizonte 6
Biên Hòa 6
Bogotá 6
Can Tho 6
Dearborn 6
Dhaka 6
Guayaquil 6
Hải Dương 6
Kunming 6
Portsmouth 6
San Diego 6
Tashkent 6
Tianjin 6
Woodbridge 6
Bexley 5
Buenos Aires 5
Totale 3.391
Salva come PNG Salva come JPEG
Nome #
Neoadjuvant chemotherapy in breast cancer: An advanced personalized multidisciplinary prehabilitation model (apmp-m) to optimize outcomes 304
BRCA mutational status, initial disease presentation, and clinical outcome in high-grade serous advanced ovarian cancer: a multicenter study 209
Development of a digital research assistant for the management of patients’ enrollment in oncology clinical trials within a research hospital 197
Multiple Bayesian network meta-analyses to establish therapeutic algorithms for metastatic triple negative breast cancer 181
Level II Oncoplastic Surgery as an Alternative Option to Mastectomy with Immediate Breast Reconstruction in the Neoadjuvant Setting: A Multidisciplinary Single Center Experience 162
Development of a digital research assistant for the management of patients’ enrollment in oncology clinical trials within a research hospital 158
Impact of bevacizumab containing first line chemotherapy on recurrent disease in epithelial ovarian cancer: A case-control study 153
BRCA Mutation Status in Triple-Negative Breast Cancer Patients Treated with Neoadjuvant Chemotherapy: A Pivotal Role for Treatment Decision-Making 152
Impact of BMI on HER2+ metastatic breast cancer patients treated with pertuzumab and/or trastuzumab emtansine. Real-world evidence 150
Secondary cytoreduction plus oxaliplatin-based HIPEC in platinum-sensitive recurrent ovarian cancer patients: a pilot study 149
Ovarian reserve after chemotherapy in breast cancer: A systematic review and meta-analysis 147
Techniques for sentinel node biopsy in breast cancer 147
Prospective Study Investigating the Efficacy and Safety of a Scalp Cooling Device for the Prevention of Alopecia in Women Undergoing (Neo)Adjuvant Chemotherapy for Breast Cancer 144
Palbociclib plus fulvestrant or everolimus plus exemestane for pretreated advanced breast cancer with lobular histotype in er+/her2− patients: A propensity score-matched analysis of a multicenter retrospective patient series 143
The prognostic relevance of HER2-positivity gain in metastatic breast cancer in the ChangeHER trial 139
Pregnancy-Associated Breast Cancer: A Multidisciplinary Approach 137
Real-world management of trabectedin/pegylated liposomal doxorubicin in platinum-sensitive recurrent ovarian cancer patients: A national survey 136
Breast cancer drug approvals issued by EMA: A review of clinical trials 135
An Innovative Scoring System to Select the Optimal Surgery in Breast Cancer after Neoadjuvant Chemotherapy 133
Accessible model predicts response in hormone receptor positive HER2 negative breast cancer receiving neoadjuvant chemotherapy 132
Development of a nomogram for predicting pathological complete response in luminal breast cancer patients following neoadjuvant chemotherapy 128
Oligometastatic Breast Cancer: How to Manage It? 125
Multigenic panels in breast cancer: Clinical utility and management of patients with pathogenic variants other than BRCA1/2 123
Palliative electrochemotherapy in primary or recurrent vulvar cancer 123
Conservative Surgery in cT4 Breast Cancer: Single-Center Experience in the Neoadjuvant Setting 118
Cdk4/6 inhibitor treatments in patients with hormone receptor positive, her2 negative advanced breast cancer: Potential molecular mechanisms, clinical implications and future perspectives 116
Role of radiomics in predicting early disease recurrence in locally advanced breast cancer patients: integration of radiomic features and RECIST criteria 114
Identification of twenty-nine novel germline unclassified variants of BRCA1 and BRCA2 genes in 1400 Italian individuals 112
Baseline 18F-FDG PET/CT for predicting pathological response to neoadjuvant chemotherapy and prognosis in locally advanced breast cancer patients: analysis of tumor and lymphoid organs metabolic parameters 111
Upfront HIPEC and bevacizumab-containing adjuvant chemotherapy in advanced epithelial ovarian cancer 111
Anthracyclines strike back: Rediscovering non‐pegylated liposomal doxorubicin in current therapeutic scenarios of breast cancer 109
Characterization of a new BRCA1 rearrangement in an Italian woman with hereditary breast and ovarian cancer syndrome 109
Malignant Mesenchymal Tumors of the Breast: Current Challenges and New Perspectives on Primary Sarcomas and Malignant Phyllodes Tumors 108
Updated Neoadjuvant Treatment Landscape for Early Triple Negative Breast Cancer: Immunotherapy, Potential Predictive Biomarkers, and Novel Agents 102
Spectrum of germline BRCA1 and BRCA2 variants identified in 2351 ovarian and breast cancer patients referring to a reference cancer hospital of Rome 101
Pregnancy-Associated Breast Cancer: A Multidisciplinary Approach 101
PI3K Inhibitors in Advanced Breast Cancer: The Past, The Present, New Challenges and Future Perspectives 98
Germline BRCA 1-2 status prediction through ovarian ultrasound images radiogenomics: a hypothesis generating study (PROBE study) 98
Impact of scalp cooling device (SCD) in preventing alopecia in women undergoing chemotherapy for breast cancer 96
Neoadjuvant Chemotherapy in Breast Cancer: An Advanced Personalized Multidisciplinary Prehabilitation Model (APMP-M) to Optimize Outcomes 95
Neoadjuvant Chemotherapy Followed by Maintenance Therapy With or Without Bevacizumab in Unresectable High-Grade Serous Ovarian Cancer: A Case-Control Study 94
Overall survival of CDK4/6-inhibitors-based treatments in clinically relevant subgroups of metastatic breast cancer: systematic review and meta-analysis 94
Level II Oncoplastic Surgery as an Alternative Option to Mastectomy with Immediate Breast Reconstruction in the Neoadjuvant Setting: A Multidisciplinary Single Center Experience 93
Clinical impact of drug-drug interactions on abemaciclib in the real-world experience of AB-ITALY study 73
PANHER study: a 20-year treatment outcome analysis from a multicentre observational study of HER2-positive advanced breast cancer patients from the real-world setting 73
Assessing the pathogenicity of BRCA1/2 variants of unknown significance: Relevance and challenges for breast cancer precision medicine 72
Neoadjuvant therapy for triple-negative breast cancer: potential predictive biomarkers of activity and efficacy of platinum chemotherapy, PARP- and immune-checkpoint-inhibitors 61
Lifestyle and environmental factors in women carrying BRCA pathogenic variants with and without cancer 34
Totale 6.000
Salva come PNG Salva come JPEG
Categoria #
all - tutte 24.808
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 24.808
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202132 0 0 0 0 0 0 0 0 0 8 17 7
2021/2022368 24 17 10 27 11 28 15 51 18 21 78 68
2022/2023761 93 102 66 126 29 100 46 57 94 14 17 17
2023/2024463 15 92 19 29 22 75 52 24 12 22 44 57
2024/20251.325 22 19 105 39 94 52 40 49 130 196 377 202
2025/20262.846 371 98 187 367 497 151 606 165 227 177 0 0
Totale 6.000